Literature DB >> 7629773

Long-term sequelae of Palmar-Plantar erythrodysaesthesia syndrome secondary to 5-fluorouracil therapy.

G K Banfield1, I D Crate, C L Griffiths.   

Abstract

Palmar-Plantar erythrodyasesthesia syndrome has been reported as a temporary complication of 5-fluorouracil therapy consisting of a debilitating erythema and tenderness of the skin of hands and feet. The syndrome has previously been observed to respond rapidly to either temporary cessation of chemotherapy or pyridoxine with little residual disability. We report a case which was characterized by persistent morbidity necessitating prolonged discontinuation of treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7629773      PMCID: PMC1295248     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


  5 in total

1.  Pyridoxine for the palmar-plantar erythrodysesthesia syndrome.

Authors:  S J Vukelja; F A Lombardo; W D James; R B Weiss
Journal:  Ann Intern Med       Date:  1989-10-15       Impact factor: 25.391

2.  Fluorouracil and the palmar-plantar erythrodysesthesia syndrome.

Authors:  J N Atkins
Journal:  Ann Intern Med       Date:  1985-03       Impact factor: 25.391

3.  Fluorouracil-associated dermatitis of the hands and feet.

Authors:  L D Feldman; J A Ajani
Journal:  JAMA       Date:  1985-12-27       Impact factor: 56.272

4.  Fluorouracil and palmar-plantar erythrodysesthesia.

Authors:  C F Curran; J K Luce
Journal:  Ann Intern Med       Date:  1989-11-15       Impact factor: 25.391

5.  Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome.

Authors:  J J Lokich; C Moore
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

  5 in total
  3 in total

1.  [Hand-foot syndrome with capecitabine therapy].

Authors:  A Marini; U R Hengge
Journal:  Hautarzt       Date:  2007-06       Impact factor: 0.751

2.  Prophylactic pyridoxine was not able to reduce the incidence of capecitabine-induced hand-foot syndrome: A meta-analysis.

Authors:  Yun Zhou; Ling Peng; Yingjie Li; Lixun Chen
Journal:  Biomed Rep       Date:  2013-08-28

Review 3.  Pyridoxine for prevention of hand-foot syndrome caused by chemotherapy: a systematic review.

Authors:  Min Chen; Lingli Zhang; Qian Wang; Jiantong Shen
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.